Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.

Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel. Eur J Cancer. 2014 Jun; 50(9):1617-27.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.